Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

Gastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.

The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.

Minerva Gastroenterology, published by EDIZIONI MINERVA MEDICA, is a notable academic journal dedicated to advancing the field of gastroenterology and related disciplines. With an ISSN of 2724-5985 and an E-ISSN of 2724-5365, this journal gathers innovative research from diverse areas including internal medicine, endocrinology, and metabolism. Though characterized by its open-access policies, Minerva Gastroenterology aims to provide a platform for high-quality scholarly articles with an emphasis on critical reviews, clinical studies, and translational research. Since its inception in 2021, the journal has managed to secure a reputation reflected in its Q3 rank across multiple categories in 2023, as well as its standing in Scopus rankings, positioning it in the 45th to 47th percentile among renowned medical journals. Situated in Turin, Italy, it fosters collaboration and knowledge-sharing among researchers and practitioners, making it an essential resource for those seeking to deepen their understanding of gastroenterological conditions and enhance clinical practices.

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Gastroenterology Insights is a premier open-access journal published by MDPI since 2009, focusing on essential research and developments within the fields of gastroenterology and hepatology. With a dedicated ISSN of 2036-7414 and E-ISSN 2036-7422, this journal serves as a vital platform for disseminating innovative studies and insights pertinent to gastrointestinal health, disorders, and treatment modalities. Based in Switzerland, Gastroenterology Insights boasts a significant academic presence, currently positioned in the Q3 quartile for both gastroenterology and hepatology categories as of 2023, reflecting its impactful contributions to the disciplines. With Scopus rankings placing it at the 94th and 48th positions in gastroenterology and hepatology respectively, the journal is committed to advancing knowledge and fostering collaboration among researchers, professionals, and students alike. By providing an open-access model, it ensures that high-quality research is accessible globally, thereby enhancing the reach and impact of crucial findings in the science of digestive health. Researchers looking to publish cutting-edge work will find Gastroenterology Insights a valuable resource for both sharing and acquiring knowledge.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.

JOURNAL OF GASTROENTEROLOGY, published by SPRINGER JAPAN KK, is a premier academic journal that has been at the forefront of gastrointestinal research since its inception in 1994. With an impressive Impact Factor and ranking in the top quartile (Q1) of its category, this journal holds a significant place in the field of gastroenterology, currently ranked 12th out of 167 in Scopus, placing it in the 93rd percentile. The journal serves as an essential platform for disseminating innovative research, clinical studies, and reviews that foster advancements in the understanding and treatment of gastrointestinal diseases. Although it does not offer Open Access options, it provides researchers, clinicians, and students access to crucial insights and breakthroughs pivotal to improving patient care and outcomes in gastroenterology. With a commitment to high-quality peer-reviewed content, JOURNAL OF GASTROENTEROLOGY plays a vital role in shaping the future of gastrointestinal health and research.